Sandoz, Mylan Slip Teva Patent Suits Over MS Drug Research
Mylan Pharmaceuticals Inc. and Sandoz Inc. on Tuesday escaped almost identical infringement suits by Teva Pharmaceuticals Ltd. after they agreed to stop using its patented technology in seeking U.S. Food and...To view the full article, register now.
Already a subscriber? Click here to view full article